Megan R. Haymart

Megan R. Haymart is Professor of Internal Medicine at the University of Michigan Medical School, holding the Nancy Wigginton Endocrinology Research Professorship of Thyroid Cancer and serving as Director of Thyroid Cancer Research since 2009. Her NIH-funded work focuses on health services research across the thyroid cancer continuum from diagnosis to survivorship.

Her educational background includes:

• Bachelor of Arts in Interdisciplinary Major (Biology, Chemistry, Art) from University of Missouri (1998)
• Doctor of Medicine from Johns Hopkins University School of Medicine (2002)
• Internal Medicine Residency at Johns Hopkins Hospital (2005)
• Endocrinology Fellowship at University of Wisconsin, Madison (2007)

Dr. Haymart's research examines thyroid cancer overdiagnosis, overtreatment, and psychosocial survivorship challenges through rigorous health services methodologies. She investigates care delivery optimization using large-scale datasets to identify evidence-based practices that improve clinical outcomes while reducing unnecessary interventions.

Analysis of her publication record reveals consistent focus on thyroid cancer epidemiology and treatment decision-making, with increasing emphasis on patient-centered outcomes and digital health solutions since 2019. Her work bridges clinical endocrinology with health policy to address systemic care delivery challenges.

Her scientific recognition includes:

• American Thyroid Association’s Van Meter Award (2017)
• University of Michigan’s Jerome Conn Award for Research Excellence (2017)
• AACE Hossein Gharib Education Lectureship Award (2021)
• Inaugural AACE Endocrine Care Innovation Award (2025)
• MICHR Distinguished Clinical and Translational Research Mentor Award (2021)
• Women in Thyroidology Woman of the Year Award (2021)

Dr. Haymart actively mentors junior faculty and trainees while leading research infrastructure development as Assistant Director of Data Solutions for AI & Digital Health Innovation and co-Director of Patient’s First. Her NIH-funded projects examine care pathways and survivorship interventions.

She directs the ThyCARE research group and contributes to multiple centers including the e-Health and Artificial Intelligence Initiative, Institute for Healthcare Policy and Innovation, and Rogel Cancer Center, driving interdisciplinary collaboration in digital health innovation.